The prognostic significance of estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: hormone receptors in risk stratification-Reference-Cited by-全球学者库

The prognostic significance of estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: hormone receptors in risk stratification

Published:2019 Issue:1 Volume:30 Page:
ISSN:2005-0380
Container-title:Journal of Gynecologic Oncology
language:en
Short-container-title:J Gynecol Oncol

Author:

Guan Jun¹²^ORCID,Xie Liying³^ORCID,Luo Xuezhen³⁴^ORCID,Yang Bingyi³⁴^ORCID,Zhang Hongwei⁵^ORCID,Zhu Qin⁶^ORCID,Chen Xiaojun³⁴^ORCID

Affiliation:

1. Department of Gynecology, Campus Virchow Clinic, Charite Medical University, Berlin, Germany.

2. Nuffield Department of Obstetrics and Gynecology, University of Oxford, Oxford, United Kingdom.

3. Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.

4. Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Shanghai, China.

5. Cervical disease diagnosis and treatment center, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.

6. Department of Pathology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.

Funder

National Natural Science Foundation of China

Publisher

Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology and Colposcopy

Subject

Obstetrics and Gynaecology,Oncology,General Medicine

Link

https://synapse.koreamed.org/pdf/10.3802/jgo.2019.30.e13

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Two lncRNA signatures with cuproptosis as a novel prognostic model and clinicopathological value for endometrioid endometrial adenocarcinoma;Aging;2023-12-11

2. Predictive and prognostic biomarkers in female genital tract tumours: an update highlighting their clinical relevance and practical issues;Pathology;2023-12

3. Treatment Patterns and Outcomes Among Patients With Advanced or Recurrent Endometrial Cancer Initiating First-Line Therapy in the United States;Journal of Health Economics and Outcomes Research;2023-10-27

4. Treatment Patterns and Outcomes Among Patients With Advanced or Recurrent Endometrial Cancer Initiating First-Line Therapy in the United States;Journal of Health Economics and Outcomes Research;2023-10-27

5. Estrogen/Progesterone Receptor Expression and Cancer Antigen 125 Level as Preoperative Predictors to Estimate Lymph Node Metastasis in Endometrioid Endometrial Cancer;International Journal of Gynecological Pathology;2023-09-08